Business
Should Cannabis Products Have Mental Health Warnings on the Packaging?
Over the last few years, high THC cannabis has caught the attention of medical professionals and parents alike – but not in a good way.
There has been an increased incidence of schizophrenia and psychosis cases attributed to consuming high THC cannabis, particularly among the youth. On the other hand, for recreational users and other types of medical marijuana patients (including those struggling with severe depression, treatment-resistant post-traumatic stress disorder, cancer, and many more), the recent development of extremely potent cannabis – with concentrates sometimes reaching as much as 95% THC – has been nothing but good news. Sure, people say that the choices we have today are definitely not your grandparents’ weed.
Thanks to developments in genetics, we now have a wide array of THC products to choose from. These range from 0.3% THC all the way up to the high 90’s. And these types of products are available in dispensaries around the nation wherever it’s been legalized for adult use, medical use, or both.
Cannabis is Safe, But Has Never Been Touted as a Cure-All
A quick look at any search engine will show you a vast array of clinical studies done that show the efficacy and safety of cannabis for treating long list of mental and physical health disorders. There has also been a great emphasis on its efficacy with mental health issues, a serious medical problem that the industry is struggling to treat with effectiveness and precision.
According to the National Alliance on Mental Health, untreated mental health disorders costs the United States some $300 billion annually due to productivity losses. In addition, mental health illness and substance abuse disorders are commonly co-occurring issues, with many of those struggling with mental health disorders turning to dangerous antidepressants that one can easily overdose on. This leads to a (preventable) increase in the death toll. People with untreated mental health disorders, especially the more serious types such as psychosis and schizophrenia, tend to self-medicate which is why they often struggle with substance use disorders.
The real problem here is the absurdly high costs of mental health care in the country. Being able to afford a therapist or psychiatrist is something that is exclusively for the rich, while only very few can access programs that are designed to help the impoverished. I mean – average therapist and psychiatric fees start at least at $100 up to $300 PER APPOINTMENT. Can we wrap our heads around this fact? And one with serious mental health problems would need several of these sessions throughout the year, maybe several a month even, just to get better.
No wonder people are self-medicating.
And with the increased access of marijuana thanks to legalization, people are self-medicating with it. And we’re seeing results that are unfortunate.
“Studies have suggested that high potency cannabis is linked to higher likelihood of psychosis, depression, anxiety, and cannabis dependence, but these studies hadn’t been able to account for people’s early mental health symptoms, and hadn’t always taken into account whether the risks of high potency use were over and above the risks from using cannabis everyday,” says a 2020 study from JAMA Psychiatry. Find Cannabis Stores Near me in the Local Directory.
So while a great majority of the population is enjoying tremendous relief from conditions that pharmaceutical drugs weren’t able to help them with, or because they simply do not want to use synthetic medications, there’s the growing minority of cases that are sounding the alarm on the easy accessibility of high THC cannabis particularly among those prone to psychosis and schizophrenia.
Cannabis advocates, even medical professionals who support the use of the drug, have never said that this miraculously medicinal plant should be seen as a cure-all.
There are certainly some circumstances wherein patients have to learn not to self-medicate with it, just in the way they could practice restraint in ensuring to follow the correct dosage for prescription drugs, or not mixing it with alcohol for fun.
Data Show Cannabis Is Generally Safe & Well-Tolerated
In numerous studies showing the efficacy of cannabis for treating a myriad of conditions, patients report that it’s usually well-tolerated.
Sure, cannabis has some well-known and common side effects. These can include paranoia, anxiety, dry mouth, red eyes, and feeling high – so much so that you’d be too impaired to drive. These are simply part of the psychoactive effects of cannabis, and science tells us that because each human being has such a unique biochemistry, we will all react to cannabis in different ways.
However, you also have to remember that cannabis is recognized as one of the safest recreational drugs in the world, even despite these minor side effects that people can experience while on it. Magic mushrooms ranks the safest, with cannabis not far behind at second place.
Furthermore, one would have to consume a ridiculously large amount of marijuana within a short time to even overdose. To date, there has not been a single case of a person overdosing from marijuana. Yes, it’s possible to take such a high amount of THC that you would feel unhinged from reality – but that would subside in a few hours.
And yes, people with cardiovascular problems should not take high THC substances. That also goes for people with severe mental health disorders, people who drive, people who have asthma, and a couple more. It’s not for everyone, but it’s certainly helping a significant percentage of the human population lead healthier and better lives.
Conclusion
To end this article, I think that cannabis should indeed have mental health warning labels. As someone who thinks that consumers should be armed with all the information they can when it comes to making a decision on their own well-being, I think that cannabis products particularly those with over 10mg of THC should indeed have warning labels – the same way that we regulate tobacco products.
If that is what it takes to increase access on marijuana and improve awareness as well as education of it, it means going on the right path to more widespread legalization, then it’s certainly for everyone’s best interest.
Business
Jio’s 1,600-Satellite LEO Constellation Gets Technical Green Light
Reliance Jio has crossed a significant milestone in its space connectivity ambitions after its proposal to deploy a Low Earth Orbit (LEO) satellite constellation of around 1,600 satellites received a positive technical assessment from the Indian National Space Promotion and Authorisation Centre (IN-SPACe).
The evaluation, conducted jointly by IN-SPACe, the Indian Space Research Organisation (ISRO), and the Wireless Planning and Coordination (WPC) wing of the Department of Telecommunications, reportedly concluded that Jio’s proposed system meets the required technical standards and is comparable to leading global satellite broadband networks.
India’s Indigenous LEO Satellite Vision
Under the proposal, Reliance Jio plans to deploy between 1,600 and 1,650 satellites in Low Earth Orbit at an altitude of around 650 kilometres.
The planned constellation is expected to provide high-speed satellite connectivity across India, with approximately 32 satellites visible from any location at a given time. The company aims to roll out the network within the next two to three years, subject to regulatory approvals.
According to industry estimates, the satellite system could deliver 4.5 to 5 terabits per second (Tbps) of total data capacity, making it one of the largest satellite broadband projects proposed in India.
The project is expected to require an investment of $10–15 billion (approximately ₹95,000 crore to ₹1.42 lakh crore), reflecting the scale of infrastructure needed for satellite manufacturing, launches, ground stations, and user terminals.
Regulatory Process Moves Forward
Following the successful technical review, the proposal is expected to move into the next phase of regulatory approvals.
The government may now assist Jio in securing orbital slots, coordinating spectrum usage, and filing applications with the International Telecommunication Union (ITU), the global body responsible for managing satellite orbit and frequency allocations.
Obtaining orbital rights remains a critical step, as Low Earth Orbit has become increasingly competitive due to the growing number of satellite broadband projects being planned worldwide.
Officials also indicated that the proposed satellite architecture has been designed to coexist with future Indian LEO constellations, allowing multiple domestic operators to share orbital resources efficiently.
Broadband, Mobile Connectivity, and Strategic Applications
Jio plans to use the satellite network to provide a range of communication services, including satellite broadband, mobile backhaul, enterprise connectivity, and direct-to-device (D2D) satellite communication, particularly in remote and underserved regions where conventional telecom infrastructure is limited.
The company also intends to establish 20 to 22 ground stations across India to support network operations.
Apart from commercial telecommunications, officials have highlighted the project’s potential strategic importance. A domestically developed satellite constellation could strengthen India’s communication infrastructure, reduce dependence on foreign satellite operators, and support national security requirements.
Reports suggest preliminary discussions are underway regarding the possibility of integrating defence-related payloads into some satellites, enabling both civilian and strategic use.
Major Step for India’s Space and Telecom Sectors
Industry analysts view the technical clearance as an important milestone in India’s expanding private space ecosystem. If Jio secures the remaining regulatory approvals and international orbital clearances, the project could become the country’s first large-scale indigenous LEO satellite broadband network.
The initiative also aligns with India’s broader efforts to expand digital connectivity while strengthening its presence in the global satellite communications market.
Business
Alleged Crores Pharma Scam Mastermind Arrested from Surat
After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.
Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.
Fake Business Deals and Dishonoured Cheques Used in Fraud
Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.
In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”
Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.
Multiple Identities and Repeated Fraud Pattern
Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.
Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.
Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.
Multi-State Surveillance Leads to Arrest in Surat
A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.
Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.
Growing Threat of Corporate Identity Fraud
The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.
Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.
Experts Urge Stronger Due Diligence in High-Value Transactions
Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.
Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.
Business
EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices
A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.
Investigation Under Digital Markets Act Gains Momentum
The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.
Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.
Industry Groups Demand Swift Action
Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.
Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.
In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.
Google Denies Allegations
Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.
However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.
Potential Billion-Euro Penalties
If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.
Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.
Wider Implications for Big Tech
The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.
A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.
As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
